About Dr Crispin Hiley

Leading private consultant clinical oncologist

Dr Hiley currently consults from:

NHS base

University College London Hospitals NHS Foundation Trust 

Private Clinics

GenesisCare UK – 14 centres across the UK

and


London Cromwell Hospital
164-178 Cromwell Rd
Kensington
London
SW5 0TU

0203 848 0900

Proton International London

1 Grafton Way
Level B4
London
WC1E 6DX 

020 4629 3598

LOC at The Harley Street Clinic

HCA Healthcare
95-97 Harley Street
London
W1G 6AF 

About Dr Hiley

Dr Crispin Hiley is a skilled, trusted, and well-known consultant clinical oncologist who currently practices at multiple hospitals and clinics across the UK.

Dr Hiley specialises in re-irradiation: the use of radiotherapy for patients who have received prior radiotherapy in the management of lung cancer, as well as oligometastatic and oligoprogressive disease of many different cancer types.

Professional background and experience

Dr Crispin Hiley has extensive experience in cutting edge treatments for lung cancer and is currently:

  • Associate professor with tenure at University College London
  • Consultant oncologist at University College London Hospital
  • Lead for lung proton therapy at UCLH
  • Chief investigator of HIT-MESO (the national proton beam radiotherapy study for patients with mesothelioma)
  • Deputy lead of clinical trials for the CRUK Lung Cancer Centre of Excellence
  • NIHR clinical research network speciality research lead radiotherapy for North London
  • Director for lung cancer for GenesisCare UK
  • Head of a research group at the UCL Cancer Institute focused on understanding resistance to radiation therapy. 

Academic background and achievements

Dr Hiley graduated with honours in medicine in 2005 at the University of Manchester before going on to undertake training across the UK and abroad at highly established hospitals, such as:

  • The Christie NHS Foundation Trust, Manchester
  • The MD Anderson Cancer Centre, Houston, USA
  • Kings College Hospital (NIHR clinical lecturer)
  • The Royal Marsden (NIHR clinical fellow).  

 

He completed a PhD at the University of London with the Barts Cancer Institute and a postdoctoral research fellowship at the Francis Crick Institute and the UCL Cancer Institute.

Published research

Dr Hiley has published a significant number of articles in some of the world’s most prestigious journals, including:

  • The Lancet
  • Nature
  • Nature Medicine
  • Science
  • New England Journal of Medicine
  • Cell
  • Cancer Cell
  • Molecular Cell
  • Cancer Discovery
  • Nature Communications
  • The International Journal of Radiation Oncology Biology and Physics

 

He has received numerous research grants to understand why some patients benefit more than others from different cancer treatments He actively contributes to ground-breaking medical research regularly.

With numerous published works and contributions to leading journals, he remains at the forefront of oncology, ensuring that his patients benefit from the latest advancements in cancer treatment. 

Dr Hiley’s specialisms

  • Chemotherapy
  • Immunotherapy
  • Radiotherapy
  • Volumetric arc therapy (VMAT)
  • Intensity modulated radiotherapy (IMRT)
  • Image guided radiotherapy (IGRT)
  • Proton beam therapy
  • Stereotactic radiotherapy (SBRT).

Expertise in proton beam therapy

Dr Crispin Hiley specialises in proton beam therapy for lung cancer, mesothelioma and thymoma. 

He is a huge advocate of proton beam therapy as it does not have the side effects typically associated with conventional radiotherapy and allows treatment of some cancers that would not be possible with conventional radiotherapy. Treatment with proton beam radiotherapy is complex and Dr Hiley has more experience than anyone in the UK in treating lung cancer patients with this technique.